Levodopa‐related motor complications—Phenomenology
Identifieur interne : 002783 ( Main/Exploration ); précédent : 002782; suivant : 002784Levodopa‐related motor complications—Phenomenology
Auteurs : Susan H. Fox [Canada] ; Anthony E. Lang [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2008.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Antiparkinson Agents (adverse effects), Cognition Disorders (chemically induced), Complication, Disease Progression, Drug Administration Schedule, Dyskinesias (etiology), Fatigue, Fluctuations, Humans, Levodopa, Levodopa (adverse effects), Levodopa (pharmacokinetics), Levodopa (therapeutic use), Mood Disorders (chemically induced), Motor Activity (drug effects), Motor fluctuations, Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson Disease (psychology), Parkinson disease, Parkinson's disease, Treatment Failure, levodopa, non‐motor.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- chemically induced : Cognition Disorders, Mood Disorders.
- drug effects : Motor Activity.
- drug therapy : Parkinson Disease.
- etiology : Dyskinesias.
- chemical , pharmacokinetics : Levodopa.
- physiopathology : Parkinson Disease.
- psychology : Parkinson Disease.
- chemical , therapeutic use : Levodopa.
- Disease Progression, Drug Administration Schedule, Fatigue, Humans, Treatment Failure.
Abstract
Long term levodopa therapy in Parkinson's disease (PD) results in a range of problems. These include fluctuations in FD symptoms termed motor fluctuations, as well as non‐motor symptoms, termed non‐motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa‐related complications. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22021
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002B11
- to stream Istex, to step Curation: 002B11
- to stream Istex, to step Checkpoint: 001339
- to stream PubMed, to step Corpus: 002053
- to stream PubMed, to step Curation: 002053
- to stream PubMed, to step Checkpoint: 002235
- to stream Ncbi, to step Merge: 002310
- to stream Ncbi, to step Curation: 002310
- to stream Ncbi, to step Checkpoint: 002310
- to stream Main, to step Merge: 003361
- to stream PascalFrancis, to step Corpus: 001131
- to stream PascalFrancis, to step Curation: 001B88
- to stream PascalFrancis, to step Checkpoint: 001208
- to stream Main, to step Merge: 003816
- to stream Main, to step Curation: 002783
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa‐related motor complications—Phenomenology</title>
<author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H." last="Fox">Susan H. Fox</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F09B7ECE2493024021E7DD0872BC2DF76FC2D171</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22021</idno>
<idno type="url">https://api.istex.fr/document/F09B7ECE2493024021E7DD0872BC2DF76FC2D171/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002B11</idno>
<idno type="wicri:Area/Istex/Curation">002B11</idno>
<idno type="wicri:Area/Istex/Checkpoint">001339</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Fox S:levodopa:related:motor</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18781677</idno>
<idno type="wicri:Area/PubMed/Corpus">002053</idno>
<idno type="wicri:Area/PubMed/Curation">002053</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002235</idno>
<idno type="wicri:Area/Ncbi/Merge">002310</idno>
<idno type="wicri:Area/Ncbi/Curation">002310</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002310</idno>
<idno type="wicri:Area/Main/Merge">003361</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0466163</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001131</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B88</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001208</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Fox S:levodopa:related:motor</idno>
<idno type="wicri:Area/Main/Merge">003816</idno>
<idno type="wicri:Area/Main/Curation">002783</idno>
<idno type="wicri:Area/Main/Exploration">002783</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levodopa‐related motor complications—Phenomenology</title>
<author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H." last="Fox">Susan H. Fox</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Neurology, Toronto Western Hospital, Movement Disorders Clinic, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Neurology, Toronto Western Hospital, Movement Disorders Clinic, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008">2008</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">S3</biblScope>
<biblScope unit="supplement">S3</biblScope>
<biblScope unit="page" from="S509">S509</biblScope>
<biblScope unit="page" to="S514">S514</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F09B7ECE2493024021E7DD0872BC2DF76FC2D171</idno>
<idno type="DOI">10.1002/mds.22021</idno>
<idno type="ArticleID">MDS22021</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term>
<term>Cognition Disorders (chemically induced)</term>
<term>Complication</term>
<term>Disease Progression</term>
<term>Drug Administration Schedule</term>
<term>Dyskinesias (etiology)</term>
<term>Fatigue</term>
<term>Fluctuations</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (pharmacokinetics)</term>
<term>Levodopa (therapeutic use)</term>
<term>Mood Disorders (chemically induced)</term>
<term>Motor Activity (drug effects)</term>
<term>Motor fluctuations</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Treatment Failure</term>
<term>levodopa</term>
<term>non‐motor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cognition Disorders</term>
<term>Mood Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesias</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Drug Administration Schedule</term>
<term>Fatigue</term>
<term>Humans</term>
<term>Treatment Failure</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Complication</term>
<term>Fluctuation</term>
<term>Lévodopa</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Long term levodopa therapy in Parkinson's disease (PD) results in a range of problems. These include fluctuations in FD symptoms termed motor fluctuations, as well as non‐motor symptoms, termed non‐motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa‐related complications. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Ontario"><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H." last="Fox">Susan H. Fox</name>
</region>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002783 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002783 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:F09B7ECE2493024021E7DD0872BC2DF76FC2D171 |texte= Levodopa‐related motor complications—Phenomenology }}
This area was generated with Dilib version V0.6.23. |